Eculizumab to Treat Thrombotic Microangiopathy/Atypical Hemolytic Uremic Syndrome -Associated Multiple Organ Dysfunction Syndrome in Hematopoietic Stem Cell Transplant Recipients
Clinical trial NCT03518203 · COMPLETED
Trial details
- NCT number
- NCT03518203
- Sponsor
- Children's Hospital Medical Center, Cincinnati
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-03
- Primary completion
- 2022-04-04
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.